ImmuCell Corporation Increase (Decrease) in Accrued Liabilities
ImmuCell Corporation (ICCC) reported Increase (Decrease) in Accrued Liabilities of $74.16 thousand for the 9-month period ending 2014-09-30, per its 10-Q filed 2014-11-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2014-11-12
- ImmuCell Corporation increase (decrease) in accrued liabilities for the quarter ending 2014-09-30 was -$91.38K.
- ImmuCell Corporation increase (decrease) in accrued liabilities for the quarter ending 2014-06-30 was $175.63K, a 230.27% increase year-over-year.
- ImmuCell Corporation increase (decrease) in accrued liabilities for the quarter ending 2014-03-31 was -$10.09K.
- ImmuCell Corporation increase (decrease) in accrued liabilities for the quarter ending 2013-12-31 was $80.99K, a 61.07% increase year-over-year.
- ImmuCell Corporation increase (decrease) in accrued liabilities for fiscal 2013 was $37.51K.
- ImmuCell Corporation increase (decrease) in accrued liabilities for fiscal 2012 was -$48.33K.
- ImmuCell Corporation increase (decrease) in accrued liabilities for fiscal 2011 was -$68.15K, a 162.53% decline from fiscal 2010.
- ImmuCell Corporation increase (decrease) in accrued liabilities for fiscal 2010 was $108.99K.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2014-09-30 | -$91.38K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $84.25K derived: sum of 2 quarters · filed 2014-11-12 | $74.16K 10-Q · filed 2014-11-12 | $155.15K derived: sum of 4 quarters · filed 2014-11-12 |
| 2014-06-30 | $175.63K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-13 | $165.54K 10-Q · filed 2014-08-13 | $246.53K derived: sum of 3 quarters · filed 2014-08-13 | $172.84K derived: sum of 4 quarters · filed 2014-11-12 |
| 2014-03-31 | -$10.09K 10-Q · filed 2014-05-14 | $70.91K derived: sum of 2 quarters · filed 2014-05-14 | -$2.79K derived: sum of 3 quarters · filed 2014-11-12 | $50.39K derived: sum of 4 quarters · filed 2014-11-12 |
| 2013-12-31 | $80.99K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26 | $7.30K derived: sum of 2 quarters · filed 2014-11-12 | $60.48K derived: sum of 3 quarters · filed 2014-11-12 | $37.51K 10-K · filed 2014-03-26 |
| 2013-09-30 | -$73.69K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | -$20.52K derived: sum of 2 quarters · filed 2014-11-12 | -$43.49K 10-Q · filed 2014-11-12 | $6.80K derived: sum of 4 quarters · filed 2014-11-12 |
| 2013-06-30 | $53.18K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-13 | $30.21K 10-Q · filed 2014-08-13 | $80.49K derived: sum of 3 quarters · filed 2014-08-13 | $56.26K derived: sum of 4 quarters · filed 2014-08-13 |
| 2013-03-31 | -$22.97K 10-Q · filed 2014-05-14 | $27.32K derived: sum of 2 quarters · filed 2014-05-14 | $3.08K derived: sum of 3 quarters · filed 2014-05-14 | -$6.41K derived: sum of 4 quarters · filed 2014-05-14 |
| 2012-12-31 | $50.29K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26 | $26.05K derived: sum of 2 quarters · filed 2014-03-26 | $16.56K derived: sum of 3 quarters · filed 2014-03-26 | -$48.33K 10-K · filed 2014-03-26 |
| 2012-09-30 | -$24.24K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | -$33.72K derived: sum of 2 quarters · filed 2013-11-13 | -$98.62K 10-Q · filed 2013-11-13 | -$126.12K derived: sum of 4 quarters · filed 2014-03-26 |
| 2012-06-30 | -$9.48K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-13 | -$74.38K 10-Q · filed 2013-08-13 | -$101.88K derived: sum of 3 quarters · filed 2014-03-26 | -$423.36K derived: sum of 4 quarters · filed 2014-03-26 |
| 2012-03-31 | -$64.89K 10-Q · filed 2013-05-14 | -$92.39K derived: sum of 2 quarters · filed 2014-03-26 | -$413.88K derived: sum of 3 quarters · filed 2014-03-26 | -$204.84K derived: sum of 4 quarters · filed 2014-03-26 |
| 2011-12-31 | -$27.50K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26 | -$348.98K derived: sum of 2 quarters · filed 2014-03-26 | -$139.94K derived: sum of 3 quarters · filed 2014-03-26 | -$68.15K 10-K · filed 2014-03-26 |
| 2011-09-30 | -$321.48K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-13 | -$112.44K derived: sum of 2 quarters · filed 2012-11-13 | -$40.65K 10-Q · filed 2012-11-13 | $83.27K derived: sum of 4 quarters · filed 2013-03-28 |
| 2011-06-30 | $209.04K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-09-07 | $280.83K 10-Q/A · filed 2012-09-07 | $404.75K derived: sum of 3 quarters · filed 2013-03-28 | $408.17K derived: sum of 4 quarters · filed 2013-03-28 |
| 2011-03-31 | $71.79K 10-Q · filed 2012-05-14 | $195.71K derived: sum of 2 quarters · filed 2013-03-28 | $199.13K derived: sum of 3 quarters · filed 2013-03-28 | |
| 2010-12-31 | $123.92K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $127.34K derived: sum of 2 quarters · filed 2013-03-28 | $108.99K 10-K · filed 2013-03-28 | |
| 2010-09-30 | $3.42K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | -$14.93K 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | -$18.35K 10-Q · filed 2011-08-15 | |||
| 2009-12-31 | -$159.97K 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |